There's nothing about Duffy's departure that passes the smell test - nothing.
I predicted this when I posted the news. I really couldn't care less whether he stays or goes because it doesn't make one bit of difference for this turd company, but his leaving does confirm that NWBO wasn't at all what he hoped it would be. If he had just bothered to read some of my posts as part of his DD before taking the job, he never would have left Merck in the first place. But alas, he had to find out for himself that the company's got nothing, has a failed trial on its hands (see the recent response to the FDA regarding guidance - probably ghost-written by Duffy - that essentially admits the trial failed), and all they were doing is sitting around figuring out how to scrounge up enough funds to keep paying themselves for another month. When he found out what NWBO was really all about and that the FDA isn't going to change its rules for a tiny piece-of-shit bio with a failed trial, he begged for his old job back and Merck said OK. His job is pretty tangential anyway - he's essentially a consultant who lives in south Florida. Who knows what he actually does to earn a salary, but I seriously doubt he's walking around with a Merck ID badge clipped to his khakis.
My only interest in posting the information was to see how long it would take for some to bend over backwards to make Duffy's departure seem like a good thing. It didn't take long. At first people were skeptical because I was the one who posted it. They didn't believe it was true. Of course, that initial skepticism and doubt betrayed their true feelings about whether Duffy's leaving the company would be a good thing (if they really thought it was a good thing, they wouldn't have shown any skepticism about it being true). But then, when they found out it was actually true, they quickly righted themselves and decided they would start spinning a new reality! Duffy saying goodbye suddenly became a good thing - just like all of the other bad things that happen to NWBO are actually good things! So, now we hear Duffy's seven-month stint was to shore up that SAP and get the FDA's sign-off (at the same time the good Dr. Bosch was taking care of things across the pond). That's right. Merck sent the good doctor over to little old NWBO to help them get that SAP wrapped up and get the FDA's blessing, which he did with flying colors (and even threw in a new Direct trial to boot)! This was all planned and executed perfectly. Mission accomplished! Time to head back to the old position at Merck! And being unlike any human being ever, he decided to forego millions and perhaps billions of dollars in personal fortune that would result from his incredibly successful seven months of work.
The same ones who told us it was a good thing when the company hired Dr. Duffy are now telling us it's a good thing he's gone seven months later. They think it's divine when the company PRs the hire of Dr. Duffy, and yet they never question for one second why the company neglected to PR his departure seven months later - even though it would seem especially odd to not send out a PR if he had indeed successfully shored up that SAP with the FDA. Why wouldn't they PR his success in getting the SAP through, the task he was hired for, instead of leaving the obvious negative explanations hanging? Hmm. I wonder.
Someone should write a book about this message board and its rampant delusions. It's a mental illness - a psychosis. There was a time when shareholders could have acted to prevent us from ending up where we are now, and perhaps we could have salvaged a promising DCVax for a new, properly executed trial. But that time has long since passed. I was saying the same thing two years ago and told you to vote no on the board/officer compensation and bonuses, and vote no on massive two thirds dilution of our shares. That would have held the company accountable and forced some hard decisions, perhaps even a right decision to declare the trial a failure, learn from their mistakes, and start over anew. But instead, all of these measures passed with overwhelming shareholder approval. I did my best to tell all of you what is really going on here, but no one would listen. What a shame. Duffy's not the only one who will be leaving soon.
